NextPharma Technologies:企業M&A・提携・投資動向

◆英語タイトル:NextPharma Technologies - Mergers and Acquisitions (M&A), Partnerships and Alliances and Investment Report
◆商品コード:MLINE60407871
◆発行会社(調査会社):MarketLine
◆発行日:2016年3月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single UserUSD350 ⇒換算¥38,150見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD700 ⇒換算¥76,300見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD1,050 ⇒換算¥114,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

SummaryMarketLine’s Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

MarketLines’ NextPharma Technologies Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by NextPharma Technologies since January 2007.

Key Findings
- Provides intelligence on NextPharma Technologies M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by NextPharma Technologies and its subsidiaries since 2007.
- Information about key financial and legal advisors for NextPharma Technologies’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons To Buy
- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about NextPharma Technologies’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

TABLE OF CONTENTS

COMPANY OVERVIEW AND KEY FACTS
–Mergers and Acquisitions – Deal reports
PARTNERSHIP
–Partnership – Overview
–Partnership – Deal reports
PRIVATE EQUITY and OWNERSHIP
–Private Equity and Ownership – Overview
–Private Equity and Ownership – Deal reports

APPENDIX
–About Datamonitor Financial Deals Database
–Deal Definition and Methodology
–About Datamonitor
–Datamonitor Professional Services Knowledge Center

LIST OF TABLES

--NextPharma Technologies activity by deal type - volume (2011 -YTD2015)
--NextPharma Technologies legal advisor ranking by value ($m)
--NextPharma Technologies financial advisor ranking by value ($m)
--NextPharma Technologies targets and partners (2011 -YTD2015)
--NextPharma Technologies partnership volume and value trend (2011-YTD2015)
--NextPharma Technologies partnership trend by key deal type (2011-YTD2015)
--NextPharma Technologies private equity and ownership volume and value trend (2011-YTD2015)
--NextPharma Technologies private equity and ownership activity by deal type (2011-YTD2015)



LIST OF FIGURES

--NextPharma Technologies activity by deal type - volume (2011-YTD2015)
--NextPharma Technologies partnership volume and value trend (2011-YTD2015)
--NextPharma Technologies partnership trend by key deal type (2011-YTD2015)
--NextPharma Technologies private equity and ownership volume and value trend (2011-YTD2015)
--NextPharma Technologies private equity and ownership by deal type (2011-YTD2015)

★海外企業調査レポート[NextPharma Technologies:企業M&A・提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asure Software, Inc. (ASUR):企業概要、財務及び戦略的SWOT分析
    Asure Software, Inc. (ASUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Morphotek, Inc.(製薬・医療分野):企業M&A動向
    Summary Morphotek, Inc. (Morphotek) is a life science company. The company discovers and develops biological-based products for the treatment of cancer, inflammatory disease and infectious diseases. Its product pipeline includes farletuzumab (MORAb-003), amatuximab (MORAb-009), MORAb-004, MORAb-022, …
  • Yiaco Medical Co:企業の戦略的SWOT分析
    Yiaco Medical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • CareGroup, Inc.:企業の戦略的SWOT分析
    CareGroup, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Boston Scientific Corporation (BSX):企業の財務及び戦略的SWOT分析
    Boston Scientific Corporation (BSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SeouLin Bioscience Co., Ltd. (038070):企業概要、財務及び戦略的SWOT分析
    Summary SeouLin Bioscience Co., Ltd. (SLB) is a biotechnology company. The company develops bio pharmaceuticals. Its products include ADSure (custom adenovirus service), and LentiSure. It offers products of various brands, such as ABT, Array Bridge, Affymefrix, Biocision, BMG LABTECH, Coy laboratory …
  • Ario Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Ario Pharma Ltd (Ario) is a drug development company that develops new therapeutics for the treatment of pain. The company develops small molecule TRPA1 antagonists to treat neuropathic and inflammatory pain. Its TRPA1 activators include pungent or noxious compounds such as allyl isothiocyan …
  • ITT Inc.:企業の戦略・SWOT・財務情報
    ITT Inc. - Strategy, SWOT and Corporate Finance Report Summary ITT Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Luminus Devices, Inc.:企業のM&A・提携動向(発電分野)
    Summary Luminus Devices, Inc. (Luminus Devices), a subsidiary of Lightera Corporation is a lighting product manufacturer that develops and manufactures solid state light sources for illumination applications. The company offers products, which include COB arrays, mid power LEDs, high brightness, whi …
  • Red Bull GmbH:企業の戦略・SWOT・財務分析
    SummaryRed Bull GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Healthways Inc.の企業概要及び財務/SWOT分析
    Healthways Inc. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forec …
  • LEIFHEIT AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' LEIFHEIT AG Mergers and Acquisi …
  • immatics biotechnologies GmbH:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' immatics biotechnologies GmbH M …
  • Seoul City Gas Co Ltd (017390):企業の財務・戦略的SWOT分析
    Seoul City Gas Co Ltd (017390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Selexys Pharmaceuticals Corporation(製薬・医療分野):企業M&A動向
    Summary Selexys Pharmaceuticals Corporation (Selexys Pharmaceuticals) is a biotechnology company. The company develops drugs for the treatment of inflammatory and thrombotic diseases. Its products include Anti-P-selectin, which blocks selectin function and prevents white blood cells from initiating …
  • Pan Orient Energy Corp. (POE)(石油・ガス分野):企業M&A動向
    Summary Pan Orient Energy Corp. (POE) is an oil and natural gas company. The company explores and produces the oil and gas in Asia. Its principal properties are divided into three distinct groups, which include partially developed concessions located on-shore Thailand, interests in production sharin …
  • Hookipa Biotech AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Hookipa Biotech AG (Hookipa) is a biotechnology company that develops vaccines and next-generation immunotherapeutics for the prevention and treatment of cancer and infectious diseases. The company's lead product candidate include HB101 vaxwave, a vaccine under development for immunization a …
  • Royal Wessanen nv:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Royal Wessanen nv Mergers and A …
  • Data Group, Inc. (DGI):企業財務及び戦略的SWOT分析
    Summary Data Group, Inc. (Data Group) is a technology service company that offers consultation and staffing services. The company provides multi channel communication solutions, IT staffing, and outsourcing services. It offers IT consulting, application outsourcing, software services, compensation m …
  • Nationwide Building Society:企業の戦略・SWOT・財務分析
    SummaryNationwide Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆